Cargando…
Outcome Analysis of Visual Acuity and Side Effect after Ruthenium-106 Plaque Brachytherapy for Medium-sized Choroidal Melanoma
PURPOSE: The purpose of this study is to report on treatment outcomes for medium-sized choroidal melanoma treated with Ruthenium-106 (Ru-106) plaque brachytherapy. METHODS: A retrospective case series of 28 patients received Ru-106 brachytherapy treatment for choroidal melanoma. The prescribed tumor...
Autores principales: | AlMahmoud, Tahra, Quinlan-Davidson, Sean, Pond, Gregory R., Deschênes, Jean |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071343/ https://www.ncbi.nlm.nih.gov/pubmed/30122856 http://dx.doi.org/10.4103/meajo.MEAJO_198_16 |
Ejemplares similares
-
Brachytherapy of Uveal Melanomas with Ruthenium-106 Plaques
por: Belaïd, Asma, et al.
Publicado: (2016) -
(106)Ruthenium eye plaque brachytherapy in the management of medium sized uveal melanoma
por: Jiang, Ping, et al.
Publicado: (2020) -
Comparison of Iodide-125 and Ruthenium-106 Brachytherapy in the Treatment of Choroidal Melanomas
por: Ghassemi, Fariba, et al.
Publicado: (2020) -
Tumor parameters predict the risk of side effects after ruthenium-106 plaque brachytherapy of uveal melanomas
por: Tarmann, Lisa, et al.
Publicado: (2017) -
Nomogram for predicting radiation maculopathy in patients treated with Ruthenium-106 plaque brachytherapy for uveal melanoma
por: Tagliaferri, Luca, et al.
Publicado: (2017)